Sign in

ASCENTAGE PHARMA GROUP INTERNATIONAL

Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16
Total revenue 0.56 0.98 0.22 0.21 0.03 0.01 0.01 0.01 0.01 0.01
Cost of revenue 0.13 0.03 0.03 0.02 0.00 0.00 0.00 0.00
Gross profit 0.43 0.95 0.19 0.19 0.02 0.01 0.01 0.01 0.01 0.01
Total operating expenses + 1.61 1.32 1.06 1.04 0.96 0.67 0.60 0.33 0.14 0.12
Operating income -1.18 -0.37 -0.87 -0.85 -0.87 -0.66 -0.58 -0.35 -0.13 -0.11
Non-operating income (net) -0.02 -0.03 -0.06 -0.04 0.04 -0.01 -0.90 -0.01 0.01 0.01
Income before tax -1.20 -0.40 -0.93 -0.89 -0.83 -0.68 -1.48 -0.36 -0.12 -0.11
Income tax expense 0.01 0.01 -0.01 0.00 -0.05 0.00 0.00 0.00 0.00
Net income -1.21 -0.41 -0.93 -0.88 -0.78 -0.68 -1.48 -0.35 -0.12 -0.11
Show Quarterly Income Statement
Mar-26 Dec-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Dec-22 Jun-22 Dec-21 Jun-21 Dec-20 Jun-20 Dec-19 Jun-19 Dec-18 Jun-18 Mar-18 Dec-17 Jun-17 Mar-17 Dec-16 Jun-16
Total revenue 0.33 0.33 0.23 0.16 0.16 0.08 0.82 0.41 0.08 0.04 0.14 0.10 0.10 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.01 0.00 0.00 0.00 0.00
Cost of revenue 0.07 0.07 0.02 0.01 0.01 0.01 0.02 0.01 0.01 0.01 0.02 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Gross profit 0.27 0.27 0.21 0.14 0.14 0.07 0.81 0.40 0.07 0.03 0.12 0.09 0.09 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.01 0.00 0.00 0.00 0.00
Total operating expenses + 0.91 0.91 0.77 0.71 0.71 0.35 0.62 0.31 0.60 0.30 0.47 0.52 0.52 0.45 0.45 0.34 0.34 0.30 0.30 0.22 0.01 0.01 0.13 0.00 0.00 0.06 0.06
Operating income -0.64 -0.64 -0.55 -0.57 -0.57 -0.28 0.19 0.09 -0.53 -0.27 -0.34 -0.42 -0.42 -0.43 -0.43 -0.33 -0.33 -0.29 -0.29 -0.34 -0.01 -0.01 -0.13 0.00 0.00 -0.06 -0.06
Non-operating income (net) 0.00 0.00 -0.03 0.01 0.01 0.00 -0.03 -0.01 0.00 0.00 -0.06 -0.02 -0.02 0.02 0.06 -0.01 -0.01 -0.45 -0.45 -0.02 0.01 0.01 0.01 0.00 0.00 0.00 0.00
Income before tax -0.64 -0.64 -0.59 -0.56 -0.56 -0.28 0.16 0.08 -0.53 -0.27 -0.40 -0.44 -0.44 -0.42 -0.37 -0.34 -0.34 -0.74 -0.74 -0.36 0.00 0.00 -0.12 0.00 0.00 -0.05 -0.05
Income tax expense 0.00 0.00 0.01 0.01 0.01 0.01 0.00 0.00 -0.01 0.00 0.00 0.00 0.00 -0.02 -0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net income -0.64 -0.64 -0.59 -0.57 -0.57 -0.28 0.16 0.08 -0.52 -0.26 -0.40 -0.44 -0.44 -0.39 -0.39 -0.34 -0.34 -0.74 -0.74 -0.34 0.00 0.00 -0.11 0.00 0.00 -0.05 -0.05
4 days ago
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16
Total cash and short-term investments + 2.47 1.24 1.07 1.49 1.71 1.02 0.88 0.97 0.40 0.45
Accounts receivable, net 0.25 0.10 0.16 0.06 0.05 0.00 0.00 0.01 0.01 0.01
Inventories 0.03 0.01 0.02 0.01 0.00 0.00
Other current assets 0.19 0.13 0.10 0.09 0.12 0.06 0.03 0.01 0.01 0.00
Total current assets 2.95 1.47 1.34 1.64 1.89 1.08 0.91 0.99 0.41 0.46
Total non-current assets + 1.02 1.14 1.16 1.19 1.05 0.65 0.30 0.24 0.17 0.13
Total assets 3.97 2.62 2.50 2.83 2.94 1.73 1.21 1.23 0.58 0.59
Total current liabilities + 1.64 1.17 0.93 0.88 0.36 0.28 0.20 0.11 0.08 0.08
Total non-current liabilities + 0.99 1.18 1.50 1.54 1.34 0.61 0.11 2.14 0.63 0.53
Total liabilities 2.63 2.34 2.43 2.42 1.71 0.88 0.31 2.24 0.71 0.61
Total stockholders' equity + 1.33 0.26 0.06 0.41 1.23 0.85 0.89 -1.01 -0.13 -0.01
Common shares outstanding 89 76 18 16 16 13 13 13 13 13
Show Quarterly Balance Sheet
Mar-26 Dec-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Dec-22 Jun-22 Dec-21 Jun-21 Dec-20 Jun-20 Dec-19 Jun-19 Dec-18 Jun-18 Mar-18 Dec-17 Jun-17 Mar-17 Dec-16 Jun-16
Total cash and short-term investments + 2.47 2.47 1.66 1.24 1.24 1.27 1.10 1.10 1.07 1.10 1.58 1.48 1.70 1.71 1.53 1.02 0.65 0.88 0.79 0.97 0.33 0.05 0.40 0.43 0.00 0.00 0.00
Accounts receivable, net 0.25 0.25 0.08 0.10 0.10 0.08 0.85 0.74 0.16 0.15 0.17 0.06 0.16 0.05 0.07 0.00 0.03 0.00 0.00 0.01 0.03 0.01 0.01 0.01
Inventories 0.03 0.03 0.01 0.01 0.01 0.01 0.01 0.01 0.02 0.02 0.01 0.01 0.01 0.00
Other current assets 0.19 0.19 0.16 0.13 0.13 0.12 0.11 0.10 0.08 0.09 0.12 0.06 0.03 0.03 0.01 0.01 0.00 0.01 0.01
Total current assets 2.95 2.95 1.91 1.47 1.47 1.47 1.96 1.96 1.34 1.34 1.76 1.64 1.87 1.89 1.60 1.08 0.67 0.91 0.83 0.99 0.38 0.06 0.41 0.44
Total non-current assets + 1.02 1.02 1.14 1.14 1.14 1.14 1.14 1.14 1.16 1.16 1.16 1.19 1.17 1.05 0.81 0.65 0.43 0.30 0.24 0.24 0.19 0.03 0.17 0.15
Total assets 3.97 3.97 3.05 2.62 2.62 2.62 3.11 3.11 2.50 2.50 2.92 2.83 3.03 2.94 2.41 1.73 1.11 1.21 1.07 1.23 0.57 0.09 0.58 0.59
Total current liabilities + 1.64 1.64 1.24 1.17 1.17 1.17 1.07 1.07 0.93 0.93 0.64 0.88 0.61 0.36 0.19 0.28 0.14 0.20 0.18 0.11 0.15 0.02 0.08 0.08
Total non-current liabilities + 0.99 0.99 1.13 1.18 1.18 1.18 1.27 1.27 1.50 1.50 1.68 1.54 1.55 1.34 0.76 0.61 0.36 0.11 2.52 2.14 0.63 0.09 0.63 0.58
Total liabilities 2.63 2.63 2.37 2.34 2.34 2.34 2.33 2.33 2.43 2.43 2.32 2.42 2.16 1.71 0.96 0.88 0.49 0.31 2.70 2.24 0.77 0.12 0.71 0.66
Total stockholders' equity + 1.33 1.33 0.67 0.26 0.26 0.26 0.77 0.77 0.06 0.06 0.59 0.41 0.88 1.23 1.45 0.85 0.61 0.89 -1.62 -1.01 -0.22 -0.03 -0.13 -0.07
Common shares outstanding 93 93 85 78 78 312 74 296 73 290 18 16 16 16 16 13 13 13 13 13 12 49 13 12 49 13 13
4 days ago
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16
Operating cash flow + -1.17 -0.11 -0.73 -0.65 -0.60 -0.61 -0.46 -0.24 -0.11 -0.05
Cash flow from investing + -1.00 -0.36 0.02 -0.38 -0.47 -0.11 -0.20 0.29 -0.23 -0.16
Cash flow from financing + 2.54 0.31 0.37 0.62 1.78 1.04 0.44 0.86 0.06 0.46
Change in cash 0.37 -0.16 -0.34 -0.42 0.71 0.32 -0.22 0.92 -0.28 0.25
Show Quarterly Cash Flow
Mar-26 Dec-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Dec-22 Jun-22 Dec-21 Jun-21 Dec-20 Jun-20 Dec-19 Jun-19 Dec-18 Jun-18 Mar-18 Dec-17 Jun-17 Mar-17 Dec-16 Jun-16
Operating cash flow + -0.78 -0.78 -0.45 0.22 0.24 0.12 -0.39 -0.18 -0.36 -0.18 -0.44 -0.34 -0.37 -0.22 -0.36 -0.31 -0.30 -0.22 -0.22 -0.12 -0.12 -0.06 -0.10 -0.02 0.00 -0.02 -0.02
Cash flow from investing + -0.30 -0.30 -0.70 -0.24 -0.23 -0.12 -0.13 -0.07 0.09 0.04 -0.06 -0.23 -0.15 0.53 -1.00 0.09 -0.21 -0.16 -0.04 0.26 0.25 0.03 -0.20 -0.19 -0.03 -0.08 -0.08
Cash flow from financing + 1.60 1.60 0.96 -0.05 -0.08 -0.04 0.43 0.20 -0.07 -0.04 0.52 0.16 0.48 0.71 1.08 0.83 0.20 0.38 0.22 0.79 0.07 0.03 0.05 0.04 0.01 0.22 0.22
Change in cash 0.52 0.52 -0.18 -0.07 -0.07 -0.03 -0.09 -0.04 -0.34 -0.18 0.02 -0.40 -0.03 1.02 -0.28 0.60 -0.31 0.00 -0.04 0.94 0.20 0.00 -0.26 -0.16 -0.02 0.12 0.12
4 days ago

ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) - Goodwill

1Y 2Y 5Y Max
9 days ago

ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) - Intangible Assets Excluding Goodwill

1Y 2Y 5Y Max
9 days ago

ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) - Intangible Assets

1Y 2Y 5Y Max
9 days ago

ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) - Total Non Current Assets

1Y 2Y 5Y Max
9 days ago

ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) - Current Net Receivables

1Y 2Y 5Y Max
9 days ago

ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) - Inventory

1Y 2Y 5Y Max
9 days ago

ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) - Cash And Short Term Investments

1Y 2Y 5Y Max
9 days ago

ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) - Cash And Cash Equivalents At Carrying Value

1Y 2Y 5Y Max
9 days ago

ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) - Total Current Assets

1Y 2Y 5Y Max
9 days ago

ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) - Total Assets

1Y 2Y 5Y Max
9 days ago